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The alarming rise in the prevalence of antibiotic resistance among pathogenic bacteria
poses a unique challenge for the development of effective therapeutic agents.
Antimicrobial peptides (AMPs) have attracted a great deal of attention as a possible
solution to the increasing problem of antibiotic-resistant bacteria. Marcin-18 was
identified from the scorpion Mesobuthus martensii at both DNA and protein levels. The
genomic sequence revealed that the marcin-18 coding gene contains a phase-I intron
with a GT-AG splice junction located in the DNA region encoding the N-terminal part of
signal peptide. The peptide marcin-18 was also isolated from scorpion venom. A protein
sequence homology search revealed that marcin-18 shares extremely high sequence
identity to the AMPs meucin-18 and megicin-18. In vitro, chemically synthetic marcin-
18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity
against Gram-positive bacteria, including some clinical antibiotic-resistant strains.
Importantly, in a mouse acute peritonitis model, these peptides significantly decreased
the bacterial load in ascites and rescued nearly all mice heavily infected with clinical
methicillin-resistant Staphylococcus aureus from lethal bacteremia. Peptides exerted
antimicrobial activity via a bactericidal mechanism and killed bacteria through membrane
disruption. Taken together, marcin-18 and its homologs have potential for development
as therapeutic agents for treating antibiotic-resistant, Gram-positive bacterial infections.
Keywords: scorpion, venom peptides, antimicrobial peptides, activity and mechanism, antibiotic resistance
INTRODUCTION
Drug resistance among bacterial pathogens is becoming an increasingly serious problem for global
public health and antimicrobial peptides (AMPs) hold promise as alternative treatment options
to traditional antibiotics. AMPs are distributed among a wide range of species and represent an
ancient host defense mechanism against infections in all living organisms, including bacteria,
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viruses, fungi, and parasites (Mygind et al., 2005; Dai et al., 2008;
Zhao et al., 2009). AMPs are usually small, positively charged
amphipathic molecules with diverse amino acid compositions
and length (Gentilucci et al., 2006). Despite their vast structural
diversity, most AMPs kill bacteria in similar ways, by membrane
disruption or pore formation that induces an eﬄux of essential
ions and nutrients (Melo et al., 2009). Their potency, low
resistance rates and unusual mode of action make AMPs an
attractive family of compounds with the potential to be developed
as therapeutic agents.
Venomous animals (scorpions, snakes, spiders, etc.) are
able to secrete toxins, both to capture prey and to protect
themselves. Numerous scorpion venom peptides have previously
been identified to have a range of antimicrobial activities
(Harrison et al., 2014) including hadrurin (Torres-Larios et al.,
2000), scorpine (Conde et al., 2000), pandinins (Corzo et al.,
2001), IsCTs (Dai et al., 2001, 2002), opistoporins, parabutoporin
(Moerman et al., 2002), mucroporin (Dai et al., 2008), imcroporin
(Zhao et al., 2009), meucins (Gao et al., 2009, 2010), Im-1
(Miyashita et al., 2010), StCTs (Yuan et al., 2010; Cao et al.,
2012b), ctriporin (Fan et al., 2011), HsAPs (Nie et al., 2012),
VmCTs (Ramirez-Carreto et al., 2012), UyCTs (Luna-Ramirez
et al., 2013), TsAPs (Guo et al., 2013), stigmurin (de Melo et al.,
2015) and Smps (Harrison et al., 2016). These findings have
indicated that AMPs from scorpion venoms can represent good
candidates for the development of new antimicrobial drugs.
Mesobuthus martensii is probably the most well-characterized
scorpion species in China. Three AMPs (BmKn2, BmKb1 and
BmKbpp) have already been functionally characterized from the
venom of M. martensii by our group. BmKn2 (13 amino acids,
1448 Da) has strong antimicrobial activity against both Gram-
positive and Gram-negative bacteria, whereas BmKb1 (18 amino
acids, 1910 Da) is only weakly inhibitory (Zeng et al., 2004).
BmKbpp (47 amino acids, 5321 Da) was found to have better
antimicrobial activity against Gram-negative bacteria thanGram-
positive bacteria (Zeng et al., 2012).
Here we have characterized another AMP (marcin-18) from
the venom of M. martensii. Based on the precursor nucleotide
sequence of marcin-18 obtained from the venom, registered into
GenBank (No. ADT89762.1) by Zhu’s lab, as well as the genome
decoded by our own group (Cao et al., 2013), we have cloned
and characterized the gene encodingmarcin-18 by comparison of
precursor nucleotide and genomic sequences. We have also used
proteomic methods to identify the existence of marcin-18 in the
venom and have evaluated the antimicrobial activity of marcin-18
and its homologs, both in vitro and in vivo. Their antimicrobial
mechanism has also been investigated.
MATERIALS AND METHODS
Genomic DNA Extraction and Gene
Cloning
Scorpions (M. martensii) were purchased from Yimeng
Mountain of Shangdong province. Genomic DNA was
extracted from the legs of one scorpion using a TIANamp
Genomic DNA Kit (Tiangen, Beijing) using proteinase
K. Based on the M. martensii genome reported by our
group, gene-specific primers were designed and synthesized
(TIANYI HUIYUAN, Wuhan). To get the full-length genomic
sequence of marcin-18, genomic DNA was amplified using
the KOD-Plus-Neo Kit (TOYOBO, Japan) with the primers
F/R (F: 5′-GGCGTACAACAGCTAATACGTT-3′; R: 5′-
CACAACCGTTAGCTATTACCAG-3′). The PCR product
was purified, inserted into the pClone007 Blunt Simple Vector
(TsingKe, Beijing), and transformed into competent Escherichia
coli DH5α cells. Positive clones were sequenced.
Venom Collection
Crude venom was obtained by the electric stimulation of telsons
(128 Hz, 20 V) and was collected into a 1.5 mL sterile Eppendorf
tube. Physiological saline was used to enhance electrical contact.
After lyophilization it was stored at−80◦C.
Separation of Venom Components by
RP-HPLC
Crude venom components were pre-separated into two parts
by 10 kDa Amicon Ultra-0.5 device (500 µL, Millipore,
United States). The filtrate with molecular weight (MW) less than
10 kDa was loaded onto an analytical XDB-C18 reverse phase
high performance liquid chromatography (RP-HPLC) column
(Welch Materials, 5 µm, 4.6 × 150 mm). The column was
eluted with 0.1% (v/v) trifluoroacetic acid (TFA) in Milli-Q water
(solvent A) and 0.1% TFA in 90% acetonitrile (solvent B) at a
flow rate of 1 mL/min using a linear gradient of 5–95% solvent
B over 60 min, followed by 95% solvent B over 10 min. Elution
was monitored by UV absorbance at 230 nm. Fractions were
collected by appearing time of each peak. The eluate was pooled,
lyophilized and stored at−20◦C before used.
LC/ESI-Q-TOF MS Analysis
The venom samples eluted from RP-HPLC with MW lower
than 10 kDa were digested by trypsin and then loaded onto an
Ultimate 3000 LC system (Dionex Ultrimate 3000), desalted and
concentrated with 0.1% formic acid (FA) on a C18 PeoMapTM
precolumn. The peptide mixtures were separated by an analytical
capillary C18 column with a linear gradient of 5–50% solvent
C (99.9% acetonitrile with 0.1% FA) over 60 min at a flow
rate of 300 nL/min. Peptides eluted from liquid chromatography
(LC) were directly injected into the coupled quadrupole-time-of-
flight mass spectrometry (Q-TOF MS) (microTOF-Q II, Bruker
Daltonics, United States) with a nano-electrospray. The peptides
were analyzed using the positive ion MS mode and data-
dependent MS/MS mode used for survey scans to detect no
less than three most abundant precursor ions. For collision-
induced dissociation (CID) in MS/MS analysis, collision energy
was selected automatically as a function of m/z and charge. The
collision gas was argon. The temperature of the heated sample
source was 150◦C and the electrospray voltage was 1200 V. The
MS/MS data acquired from LC/ESI-Q-TOF MS were matched
against genomic and transcriptomic databases ofM. martensii by
Mascot searching and proteins were identified (Xu et al., 2014).
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Peptide Synthesis, Characterization and
Sequence Analysis
The peptides used in this study were synthesized by GL Biochem
(Shanghai, China) and amidated at the C-terminus with a purity
of >95%. Peptide purity (>95%) was assessed by RP-HPLC with
a semipreparative C18 column (Elite, 5 µm, 10× 250 mm) using
a linear gradient of 5–95% solvent B in 60 min at a constant
flow rate of 5 mL/min. Their actual MWs were confirmed by
matrix-assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI-TOF MS). A 1 µL aliquot of each peptide
was spotted onto the target plate along with an equal volume of
a matrix solution (10 mg/mL α-cyano-4-hydroxycinnamic acid
(CHCA), 50% acetonitrile, and 0.1% TFA). The mixture was left
to dry at room temperature.Mass spectrometry was performed by
the FlexControl software (m/z range of 770–3500). The reflection
mode and the accelerating voltage of 25 kV were chosen for work.
The helical wheel projection was performed online using the
Heliquest analysis.1
Circular Dichroism (CD)
CD measurements (ambient temperature) of each peptide
at a final concentration of 100 µg/mL were recorded in
water, 30% trifluoroethanol (TFE) and 70% TFE on a J-810
spectropolarimeter (Jasco, Tokyo, Japan) at 190–260 nm. Spectra
were collected from three separate recordings.
Bacterial Strains
Staphylococcus aureus AB94004, Staphylococcus aureus
ATCC6538, Staphylococcus aureus ATCC25923, Staphylococcus
aureus AB208193, Staphylococcus epidermidis AB208187,
Staphylococcus epidermidis AB208188, Micrococcus luteus
AB93113, Bacillus thuringiensis AB92037, Bacillus subtilis
AB91021, Escherichia coli AB94012, Pseudomonas aeruginosa
ATCC9027, and Escherichia coli ATCC25922 were purchased
from the China Center of Type Culture Collection (CCTCC).
Methicillin-resistant Staphylococcus aureus (MRSA) P1374,
methicillin-resistant Staphylococcus aureus (MRSA) P1381, and
penicillin-resistant Staphylococcus aureus (PRSA) P1389 were
obtained from the 302nd military hospital of Beijing, China.
Antimicrobial Assays
The antimicrobial activity was determined via a broth
microdilution assay according to the procedure recommended
by the Clinical and Laboratory Standards Institute with some
modifications (Hou et al., 2011; Li et al., 2016). Bacteria were
cultured in Luria-Bertani (LB) broth to OD600 = 0.6 at 37
◦C,
then diluted to 105–106 CFU/mL in LB medium. Peptides were
serially double diluted to a gradient concentration range from
48.3 to 1.5 µM in physiological saline. Eighty microliters of the
bacterial suspension and 20 µL of diluted peptide at varying
concentrations were added to 96-well plates, and then incubated
for 16–18 h at 37◦C with continuous shaking at 250 rpm. The
antimicrobial activity of ampicillin and kanamycin were also
tested as positive controls. Experiments were performed in
1http://heliquest.ipmc.cnrs.fr/cgi-bin/ComputParamsV2.py
triplicate. The minimum inhibitory concentration (MIC) was
determined as the lowest peptide concentration at which no
bacterial growth was observed.
Salt and pH Stability Assays
Seventy micrograms of synthetic peptide was dissolved in 0, 50,
100, 150, 200, and 250 mM sterile NaCl solutions, respectively.
MICs of the peptides against S. aureusAB94004 were determined
with increasing salt concentrations. Experiments were performed
in triplicate. In addition, the peptide in physiological saline was
used as a control.
To determine pH stability, 70 µg peptide was adjusted to
a pH range from 3.0 to 10.0 with the following sterile buffers
according to previous protocol (Cao et al., 2015): 0.1 M citric
acid-sodium citrate buffer (pH 3.0–5.0), 0.2 M sodium phosphate
buffer (Na2HPO4-NaH2PO4) (pH 6.0–7.0), 0.05 M Tris–HCl
buffer (pH 8.0–9.0), and 0.05 M glycine-NaOH buffer (pH 10.0).
The antimicrobial activity of peptides against S. aureus AB94004
was tested using MIC assays.
Mouse Peritonitis Model
Six to eight-week-old male BALB/c mice (18–21 g) were
purchased from the Animal Center for Disease Control and
Prevention (Hubei, China) and maintained under specific
pathogen-free conditions at 25 ± 2◦C and 50 ± 5% humidity,
on a 12 h/12 h light/dark cycle.
All methods were performed in accordance with the relevant
guidelines (Dai et al., 2008; Peng et al., 2017). The mice were
intraperitoneally (i.p.) injected with 0.5 mL/mouse (5.85 × 107
CFU) of the exponential phase MRSA P1381 inoculum in
physiological saline containing 5% (wt/v) mucin. At 1 h
after the bacterial infection, the mice were i.p. injected with
0.4 mL/mouse of physiological saline (I) (to serve as a negative
control), marcin-18 peptide (10 mg/kg) (II), marcin-18 peptide
(25 mg/kg) (III), meucin-18 peptide (25 mg/kg) (IV), megicin-18
peptide (25 mg/kg) (V), and vancomycin (25 mg/kg) (VI). The
vancomycin dose was set based on previous studies (Cavanagh
et al., 2013; Wang et al., 2018). Each group included 6 mice.
After another 24 h post administration, subject peritonea were
lavaged with 1 mL of physiological saline and lavage fluids were
then collected. Ascites were diluted and plated on LB agar so that
the number of bacterial colonies could be counted. The ability
of the three peptides to rescue mice from lethal bacteremia was
observed 2–4 times daily and survival was tracked for 7 days.
Time-Killing Kinetics
S. aureus AB94004 were grown to exponential phase
(OD600 = 0.5) and diluted to ca. 10
7 CFU/mL in LB broth,
prior to the addition of peptide solutions at 1 × MIC, 2 × MIC
and 4×MIC and kanamycin at 4×MIC to the cell suspensions.
Physiological saline and melittin were used as negative and
positive controls. At each time point (0, 5, 15, 30 and 60 min),
aliquots were taken and washed with physiological saline, and
then diluted appropriately in the physiological saline. The
surviving bacterial colonies were quantitated after the cells were
spread on LB agar and incubated overnight at 37◦C.
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Competition Assays
1 mg/mL of peptides were incubated with an equal volume
of 5 mg/mL of the lipopolysaccharide (LPS, Sigma-Aldrich:
L3012/L8643) or lipoteichoic acid (LTA, Sigma-Aldrich: L2515)
for 30 min. TheMICs of peptides treated with LPS or LTA against
S. aureus AB94004 were subsequently measured.
Fluorescence Measurements
S. aureus AB94004 were cultured to exponential phase (ca. 107
CFU/mL), centrifuged and suspended in physiological saline.
Then the fluorescence dye SYTOX green (Invitrogen) was added
at a final concentration of 5 µM. After incubation for 10 min,
50 µL bacterial culture and equal volume of peptides serially
diluted in physiological saline at final concentrations of 1×MIC,
2 × MIC, and 4 × MIC were added in a Greiner 96-well flat-
bottom black plate. Physiological saline and MSI 78 were used as
negative and positive controls. Fluorescence was measured over
30 min at the excitation and emission wavelengths of 488 and
525 nm, respectively.
Transmission Electron Microscopy (TEM)
The exponential phase bacteria S. aureus AB94004 (ca. 107
CFU/mL) were incubated with peptides at the final concentration
of 4 ×MIC or without the peptides for 30 min at 37◦C. Samples
were harvested by centrifugation and washed with physiological
saline. The samples were then semi-thin sectioned and examined
by a Hitachi H-8100 transmission electron microscope.
Statistical Analysis
The data were analyzed using the GraphPad Prism 6. Continuous
variables are expressed as the mean ± standard error of the
mean (SEM).
RESULTS
Gene Organization and Structure of
Marcin-18 From the Scorpion
M. martensii
The precursor nucleotide sequence of marcin-18 has been
registered into GenBank (No. ADT89762.1) by Zhu’s lab. The
cDNA sequence consists of a 5′ UTR of 61 nt, an ORF of
237 nt, and a 3′ UTR of 68 nt. A single polyadenylation
signal (aataaa) was found 13 nt upstream of the poly (A)
tail. The ORF of 237 nt was predicted to encode a precursor
that consists of 78 amino acid residues, containing a putative
23-residue signal peptide, a 37-residue propeptide and an 18-
residue mature peptide (FFGHLFKLATKIIPSLFR) (Figure 1B).
Multiple sequence alignments revealed that marcin-18 has
high homology (94.44%) with meucin-18 (Gao et al., 2009)
and megicin-18 (Diego-Garcia et al., 2014), AMPs from the
venoms of the scorpions Mesobuthus eupeus and Mesobuthus
gibbosus, respectively, suggesting that marcin-18 peptide may
have antimicrobial activity.
To determine the gene organization and structure of marcin-
18, we designed primers and amplified the genomic sequence of
marcin-18 according to the genome of M. martensii decoded by
our group (Cao et al., 2013). The PCR product was a single band
with a size of approximately 3.5 kb (Figure 1A). The amplified
DNA band was purified and sequenced. After DNA sequence
analysis, the full-length genomic DNA sequence of the gene
encoding marcin-18 was obtained (Figure 1B). A comparison of
the genomic sequence with the corresponding cDNA sequence
revealed that the gene contained a phase-I intron with a length of
2536 nt, located in the DNA region encoding theN-terminal part
of signal peptide, which has a consensus GT-AG splice junction
(Figure 1C). The A+T content of the intron is 62.78%, which
is lower than that of both exon 1 (71.43%) and exon 2 (63.83%).
The majority of toxin genes from scorpion venoms have a generic
structure comprising two exons surrounding a single intron:
the first exon encodes the first two-thirds of the signal peptide,
whereas the second exon encodes the last third of the signal
peptide, the mature peptide and the propeptide.
Identification of Marcin-18 in the Venom
of M. martensii
In order to identify the presence of marcin-18 in the crude
venom of M. martensii, we employed a combined strategy of
ultrafiltration and LC-MS (Figure 2A) to verify its existence.
Firstly, the crude venom was separated into “high” and “low”
MW fractions by ultrafiltration through a 10 kDa cut-off
membrane. The “low” MW filtrate was then analyzed by RP-
HPLC and LC/ESI-Q-TOF MS. All MS/MS data were collected
and searched against genomic and transcriptomic databases of
M. martensii by Mascot. Identified sequences were annotated
by homology searching in the NCBI database combined
with descriptions in UniProt. Marcin-18 (comp66_c0_seq1_4)
was identified and displayed high-quality ESI-Q-TOF MS/MS
spectrum (Figure 2B).
Chemical Synthesis and Quality Analysis
of Marcin-18 and Its Homologs
Because of the extremely small amounts of marcin-18 in crude
venom, the peptide was synthesized by solid state methods, in
order to provide enough material for further studies. Bacterial
recombinant expression systems are not very useful in this
regard due to the inherent propensity of their products to
lyse prokaryotic cell membranes. Marcin-18 and its homologs
(meucin-18 and megicin-18) were synthesized using N-(9-
fluorenyl) methoxycarbonyl (Fmoc) chemistry and C-terminal
amidation. All peptides were >95% pure (HPLC) and verified by
mass spectrometry: the calculatedMWofmarcin-18 was 2134.25,
corresponding to its theoretical value 2134.63; the calculated
MW of meucin-18 was 2106.01, corresponding to its theoretical
value 2106.57; the calculated MW of megicin-18 was 2068.04,
corresponding to its theoretical value 2068.56 (Figure 3).
Structural Characteristics of Marcin-18
and Its Homologs
When plotted as helical wheel projections (Figures 4A,C,E) using
the online program Heliquest (Gautier et al., 2008), marcin-
18 and its homologs adopted an amphipathic structure, where
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FIGURE 1 | PCR amplification and genomic organization of marcin-18 coding gene. (A) PCR amplification of marcin-18 genomic region. Marker: 10 Kb DNA ladder.
(B) Genomic sequence (above) and corresponding amino acid sequence (below) of marcin-18 gene. Red capital letters are signal peptide, mature peptide and
propeptide coding regions. Lowercase letters are 5’ UTR, intron and 3’ UTR, respectively. The signal peptide residues are underlined. The mature peptide residues
are shaded in gray. The potential post-translation cleavage site is marked in rectangle. The polyadenylation signal sequence (aataaa) is underlined in blue. Terminator
is indicated by a pound sign (#). (C) The gene structure of marcin-18. The signal peptide (SP), mature peptide (MP) and pro-peptide (PP) are shown. Intron is
designated by a straight line.
hydrophobic residues are on one side while charged and neutral
polar residues are found on the other side. On the hydrophilic
side, Arg18 and His4 (marcin-18) are changed to Gln18 (meucin-
18) and Ala4 (megicin-18), respectively. Structural differences
between synthetic peptides, in either water or aqueous TFE,
were confirmed by secondary structure analysis using CD
spectroscopy (Figures 4B,D,F). All peptides exhibited random
coil structures in water; however, they showed high percentages
of α-helix in either 30 or 70% aqueous TFE. This suggests
that peptides can form amphipathic α-helical structures in
the appropriate membrane environment. Previous reports have
suggested that hydrophobic and electrostatic interactions are
the two main driving forces in peptide-membrane interactions
(Shai, 1999; Yeaman and Yount, 2003). Our data suggests that
marcin-18 and its homologs might follow this pattern.
In Vitro Antimicrobial Activity of
Marcin-18 and Its Homologs
The antimicrobial activities of marcin-18 and its homologs
were studied and their MICs are shown in Table 1. With
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FIGURE 2 | Identification of marcin-18 in the natural venom of the scorpion M. martensii. (A) Schematic overview of combined strategy for proteomic analysis of the
M. martensii venom. (B) Identification of marcin-18 by ESI-Q-TOF MS combined with Mascot searching. The peptide sequence identified by Mascot searching was
comp66_c0_seq1_4 from the transcriptome database of M. martensii. Protein identification probability, molecular weight and percentage of amino acids identified
(shadowed in yellow) are shown. MS/MS spectrum of one amino acid sequence (m/z 629.87 (2+)) is shown. The amino acid sequence was confirmed by analyzing
an, bn, and yn ions derived. The actual peptide mass is 1257.73 Da.
the exception of the Gram-positive Micrococcus luteus (MICs
23.4–48.3 µM), peptides generally had greater activities against
Gram-positive organisms (MICs 1.5–3.0µM) than against Gram-
negative organisms (MICs 5.9–48.3 µM). Marcin-18 and its
homologs were also tested against antibiotic-resistant bacteria.
The antibiotic-resistant bacteria were clinical isolates, all of
which were tested with traditional antibiotics to determine
their resistance. MICs against PRSA and MRSA varied between
1.5 and 3.0 µM. These data suggest that these peptides are
more effective in inhibiting antibiotic-resistant pathogens than
many commercially available antibiotics (Cao et al., 2012a).
MICs of AMPs (BmKn2, BmKb1 and BmKbpp) derived
from M. martensii and antibiotics (ampicillin, kanamycin and
vancomycin) are also shown (Zeng et al., 2004, 2012; Cao et al.,
2012a). Marcin-18 and its homologs have greater antimicrobial
activity than these other AMPs and some antibiotics.
Effect of Salt and pH on Activity of
Marcin-18 and Its Homologs
The three peptides retained stable antibacterial activity against
S. aureus AB94004 in the NaCl range of 0–250 mM (Figure 5A).
Meanwhile, marcin-18 and megicin-18 exhibited stable activity
against S. aureusAB94004 in an acidic environment (pH 3.0–5.0),
but it was reduced in neutral and alkaline environments
(pH 6.0–10.0). Meucin-18 has great tolerance to the acidic,
neutral and alkaline environments (Figure 5B).
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FIGURE 3 | Chemical synthesis and characterization of marcin-18 and its homologs. (A) Physiochemical properties of marcin-18 and its homologs. RP-HPLC
analysis of the synthetic marcin-18 (B), meucin-18 (D) and megicin-18 (F). Mass spectra of the synthetic marcin-18 (C), meucin-18 (E) and megicin-18 (G)
measured by MALDI-TOF.
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FIGURE 4 | Secondary structure analysis of marcin-18 and its homologs. Helical wheel diagram of synthetic marcin-18 (A), meucin-18 (C), and megicin-18 (E)
determined by the Heliquest method. The representation as a helical wheel shows the hydrophilic face and hydrophobic face. Basic (positive charged) residues are
highlighted by blue background. Hydrophobic (non-polar) residues are highlighted by yellow background. Polar uncharged residues are highlighted by purple
background. P (Pro) is a special residue shown by green background. CD spectra of marcin-18 (B), meucin-18 (D), and megicin-18 (F) (100 µg/mL) in water alone
or with 30 or 70% aqueous TFE.
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TABLE 1 | In Vitro antimicrobial activities of marcin-18 and its homologs compared with other peptides and antibiotics.
Strains MIC (µM)
Marcin-18 Meucin-18 Megicin-18 BmKn2 BmKb1 BmKbpp Amp Kana Van
Gram-positive bacteria
Staphylococcus aureus AB94004 1.5 1.5 1.5 4.3 – – 67.3 5.4 –
Staphylococcus aureus ATCC6538 1.5 1.5 1.5 – – – – – –
Staphylococcus aureus ATCC25923 2.9 3.0 3.0 4.3 – – – 10.7 –
Staphylococcus aureus AB208193 2.9 3.0 3.0 – – – – – –
Staphylococcus aureus ATCC14458 – – – – – > 70 – – –
Staphylococcus aureus – – – – 8.4 – – – –
Staphylococcus epidermidis AB208187 2.9 3.0 1.5 – – – – – –
Staphylococcus epidermidis AB208188 2.9 1.5 1.5 – – – – – –
Micrococcus luteus AB93113 23.4 47.5 >48.3 4.3 42.6 – – – –
Micrococcus luteus ATCC9341 – – – – – 20.3 – – –
Bacillus thuringiensis AB92037 2.9 3.0 1.5 8.6 – – – – –
Bacillus subtilis AB91021 2.9 3.0 3.0 8.6 25.5 – – 42.9 –
Bacillus subtilis ATCC6051 – – – – – 24.4 – – –
Listeria monocytogenes ATCC35152 – – – – – 5.7 – – –
Enterococcus faecalis ATCC14508 – – – – – 57.1 – – –
Nocardia asteroids ATCC3308 – – – – – >70 – – –
Gram-negative bacteria
Escherichia coli AB94012 11.7 23.7 >48.3 >69 – – – – –
Escherichia coli ATCC25922 5.9 11.9 12.1 >69 – – 33.7 21.5 –
Escherichia coli DH5α – – – – – 2.3 – – –
Escherichia coli – – – – 9.5 – – – –
Pseudomonas aeruginosa ATCC9027 5.9 11.9 12.1 – – – – – –
Pseudomonas aeruginosa AB93066 – – – 34.5 – – – – –
Pseudomonas aeruginosa ATCC9229 – – – – – 4.7 – – –
Pseudomonas aeruginosa – – – – 47.5 – – – –
Haemophilus influenzae ATCC31517 – – – – – 3.2 – – –
Klebsiella pneumoniae ATCC13882 – – – – – 2.8 – – –
Salmonella enterica ATCC8090 – – – – – 2.3 – – –
Serratia marcescens ATCC13880 – – – – – 68.2 – – –
Penicillin resistant bacteria
PRSA P1383 – – – 8.6 – – – – 4.2
PRSA P1389 2.9 3.0 1.5 8.6 – – – – 4.2
Methicillin resistant bacteria
MRSA P1369 – – – 8.6 – – – – 4.2
MRSA P1374 2.9 3.0 3.0 8.6 – – – – 4.2
MRSA P1381 1.5 1.5 3.0 8.6 – – – – 2.1
MRSA P1386 – – – 8.6 – – – – 2.1
In Vivo Antimicrobial Activity of
Marcin-18 and Its Homologs
We further explored the antibacterial and protective ability
of marcin-18 and its homologs in a mouse model of lethal
peritonitis. The optimally infective dose for BALB/c mice was
determined to be approx. 108 CFU/mL. Mice were inoculated
intraperitoneally with 5.85× 107 CFU of MRSA P1381, followed
by intraperitoneal treatment with a single dose of synthetic
peptide or vancomycin (n = 6) at 1 h after bacterial injection.
The mice were inspected for 7 days. As shown in Figure 5C,
all six mice in the negative control group (MRSA, no peptide,
physiological saline) died after infection within 3 days, but half
the mice treated with marcin-18 (10 mg/kg) survived the study
period. 100% of the mice survived in groups that had been
treated, either with marcin-18 (25 mg/kg) or with vancomycin
(25 mg/kg). In a separate experiment with marcin-18 analogs,
83.3% (5/6 mice) survived after treatment with meucin-18
(25 mg/kg) and 100% of mice survived after treatment with
megicin-18 (25 mg/kg) (Figure 5D). In all cases, the surviving
mice were unaffected and behaved normally.
The success of this treatment was also evaluated by the
decrease in peritoneal bacterial counts of peptide-treated mice
compared with untreated control mice and vancomycin-treated
mice. 24 h after the bacterial infection, the bacterial load
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FIGURE 5 | In vitro salt/pH stability and in vivo antimicrobial activity of marcin-18 and its homologs. (A,B) Effect of salt and pH on the antibacterial activity of
marcin-18 and its homologs. (C,D) Therapeutic efficacy of marcin-18 and its homologs on MRSA infected mice. Vancomycin was used as the antibiotic control.
There were six mice in each group. The infected mice were inspected 2–4 times each day and survival were tracked for 7 days. (E,F) Quantitative comparison of
peritoneal bacterial counts of mice treated with physiological saline versus those of mice treated with peptides at 24 h after peptide administration. Physiological
saline was used as the negative control. Each point represents data from a single mouse. Mean values are presented, n = 6. Error bars indicate ± SEM. The data
were subjected to a one-way analysis of variance (ANOVA) and significant differences between the means were evaluated. A probability value of < 0.05 was
considered significant. ∗∗p < 0.01 for physiological saline versus meucin-18. ∗∗∗p < 0.001 for physiological saline versus marcin-18 and megicin-18.
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in the ascites of control mice was approximately 108 CFU.
Administration of marcin-18 significantly reduced the bacterial
load in ascites by about 5 × 106 CFU compared with that
of mice in the physiological saline-treated group (P < 0.001)
(Figure 5E). The treatments with meucin-18 and megicin-18
markedly decreased the bacterial load of mice with bacteremia
by approx. 106 CFU (P < 0.01) and 107 CFU (P < 0.001)
respectively (Figure 5F), compared with those of control
mice. Mice in the antibiotic-treated group had few detectable
bacteria. Collectively, these results suggest that marcin-18 and
its homologs have antimicrobial activity in vivo, as well as
suggesting that the peptides, over the time period studied, are not
cytotoxic.
Antibacterial Mechanism of Marcin-18
and Its Homologs
To gain insights into the antibacterial mechanism of marcin-18,
meucin-18, and megicin-18, S. aureus AB94004 was used as a
model bacterium to investigate the exact mode of action of these
peptides. Using a time-killing assay, the killing rate increased with
increasing peptide concentration. Marcin-18 (Figure 6A) and
meucin-18 (Figure 6B) rapidly killed bacterial cells and achieved
an approx. 2-lg reduction in 5min and within 15min at 1×MIC.
Viable colony number decreased approximately 15% in 5 min at
1×MIC in the presence of megicin-18 (Figure 6C).
To determine whether LPS or LTA interfered with the
antibacterial activities of marcin-18, meucin-18, and megicin-18,
peptides were mixed with LPS or LTA and MIC values against
S. aureus were re-measured. MICs of marcin-18 (Figure 6D)
and megicin-18 (Figure 6F) were reduced by only two-fold and
meucin-18 (Figure 6E) was unchanged. These results suggest
that the LPS from E. coli (LPS 1) or P. aeruginosa (LPS 2) and
LTA from S. aureus do not significantly affect the antimicrobial
properties of the three peptides.
To further assess whether these peptides could damage
the integrity of the bacterial cell membrane, S. aureus were
pre-treated with the fluorescent nucleic acid stain SYTOX
green before incubating with each of the peptides in separate
experiments. The fluorescence had a rapid increase over 5 min at
1 × MIC of marcin-18 (Figure 6G) and megicin-18 (Figure 6I)
and 2 × MIC of meucin-18 (Figure 6H) when S. aureus cells
were exposed to SYTOX and the peptides, compared with a
stable increase upon exposure to MSI 78 (the positive control).
However, the fluorescence did not have an apparent increase over
30 min at 1×MIC of meucin-18 (Figure 6H). When treated with
2 × MIC and 4 × MIC of marcin-18 (Figure 6G) and megicin-
18 (Figure 6I), the fluorescence reached to the maximum value
before detected. These results indicated that these peptides killed
the bacteria by fastly disrupting the bacterial membrane.
To determine the direct influence of these peptides on
the bacteria, TEM was used to examine the ultrastructural
changes of S. aureus after treatment with peptides. Untreated
cells of S. aureus were round, proliferating cell with intact
cell wall and well-defined membrane (Figures 6J,N). After
treatment (4 × MIC) with either marcin-18 (Figures 6K,O),
meucin-18 (Figures 6L,P), or megicin-18 (Figures 6M,Q)
for 30 min, disruption of the cell envelope was observed,
together with the appearance of a granulated cytoplasm.
These morphological changes support our previous experiments,
providing evidence for peptide-induced disruption of the
bacterial plasma membrane.
DISCUSSION
There is an urgent need for more effective agents to overcome
drug resistance in bacteria. In addition to the three AMPs
(BmKn2, BmKb1, and BmKbpp) already characterized from the
venom of the Chinese scorpion M. martensii, we have identified
and functionally characterized a new AMP (marcin-18). Using
the marcin-18 precursor sequence as a query to blast in the
NCBI database, we found high similarity to precursors ofmeucin-
18 and megicin-18, AMPs from M. eupeus and M. gibbosus,
respectively. In the present study, we have synthesized the
three peptides and investigated their antimicrobial activity and
mechanism action.
Marcin-18 and its homologs had a wide spectrum of
antimicrobial activity in vitro against Gram-positive and Gram-
negative bacteria. They had better inhibitory activity against
Gram-positive bacteria than Gram-negative bacteria. It is
tempting to suggest that differences in themolecular composition
of Gram-positive vs Gram-negative bacterial membranes are
responsible for this selectivity although at present we cannot offer
any meaningful insights in this regard. Our in vivo study with
a mouse model of lethal peritonitis has also demonstrated that
peptide-treated mice have a high survival rate, suggesting that
these peptides were still active in the peritoneal cavity.
Our data suggests that major negatively charged components
of the prokaryotic cell wall (e.g LPS and LTA) do not have a
detrimental effect on the antimicrobial activity of marcin-18 and
its homologs. In contrast to some previous results (Fjell et al.,
2011) our studies also indicate that LPS and LTA are not the
primary site of antimicrobial action of these peptides.
Structure analysis suggested that marcin-18 and its homologs
are amphipathic, cationic, α-helical peptides. Usually, natural
AMPs with such structures are considered to be membrane-lytic
peptides (Yamaguchi et al., 2001; Yang et al., 2001), which kill
bacteria within 2–3 min of initial exposure (Hartmann et al.,
2010; Huang et al., 2010). They bind to bacterial membranes and
often non-specifically increase membrane permeability, resulting
in the leakage of intracellular components (Peng et al., 2017).
The rapid degradation of S. aureus, as evidenced by cytoplasmic
membrane permeation assays and TEM have demonstrated
that marcin-18 and its homologs are classical membrane-lytic
peptides. Though these cationic peptides do not interact with
either LPS or LTA, there are many other negatively charged
molecules on the outer surface of the bacterial cell; electrostatic
interactions between the peptides and the bacterial surface will
encourage these peptides to pass through the cell envelope
(Brogden, 2005).
Although AMPs such as marcin-18 and its homologs
have potential advantages over conventional antibiotics,
since their mechanism of action makes the development of
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FIGURE 6 | Antibacterial mechanism of marcin-18 and its homologs. Time-killing kinetics of marcin-18 (A), meucin-18 (B) and megicin-18 (C) against S. aureus
AB94004. The assay was performed by determining the counts of surviving bacteria. 0 h represents bacteria before treatment. Negative controls: physiological
saline and kanamycin. Melittin was used as a positive control. The MICs of kanamycin and melittin against S. aureus AB94004 were 5.4 µM and 2.2 µM. MICs of
marcin-18 (D), meucin-18 (E) and megicin-18 (F) treated with LPS or LTA against S. aureus AB94004. LPS 1 and LPS 2 are from E. coli and P. aeruginosa.
Fluorescence measurements of marcin-18 (G), meucin-18 (H) and megicin-18 (I). Negative control: physiological saline. MSI 78 is an amphipathic α-helical peptide
with an antibacterial mechanism of disrupting the membrane. The MIC of MSI 78 against S. aureus AB94004 was 2.5 µM. Mean values are presented, n = 3. Error
bars indicate ± SEM. Transmission electron microscopy analysis of S. aureus AB94004 treated with marcin-18 (K,O), meucin-18 (L,P) and megicin-18 (M,Q). (J,N)
Negative control. Treatment with the peptides at the concentration of 4 × MIC for 30 min.
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bacterial resistance more unlikely, obstacles still remain in their
progression to drugs of therapeutic usefulness. One of the biggest
challenges is to develop AMPs that selectively permeabilize
bacterial membranes and therefore eliminate potential cytotoxic
effects in mammalian cells. Our studies with the lethal peritonitis
mouse model, demonstrating that marcin-18 and its homologs
can rescue mice from a lethal dose of MRSA, offers great promise
in this regard.
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